Thursday, March 30, 2023
WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.
Professor of Endocrinology and Metabolism
Chief, Section of Diabetes and Metabolic Diseases
University of Pisa
Pisa, Italy
Medical Director and Principal Investigator
National Research Institute
Los Angeles, California, United States
Assistant Clinical Professor of Medicine
Division of Endocrinology
University of California San Diego
San Diego, California, United States
Professor of Endocrinology and Metabolism
Chief, Division of Endocrinology
University Hospital Policlinico Consorziale
University of Bari Aldo Moro
Bari, Italy
Clinical Professor of Medicine
University of Washington
School of Medicine
Rockwood/MultiCare Center for Diabetes and Endocrinology
Spokane, Washington, United States
None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
This activity is intended for diabetologists/endocrinologists and primary care providers (PCPs).
The goal of this activity is to increase awareness of novel dual incretin-based therapies and first clinical data from the SURPASS phase 3 program with tirzepatide as presented at the American Diabetes Association (ADA) virtual congress 2021.
Upon completion of this activity, participants will:
WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.
Professor of Endocrinology and Metabolism
Chief, Section of Diabetes and Metabolic Diseases
University of Pisa
Pisa, Italy
Medical Director and Principal Investigator
National Research Institute
Los Angeles, California, United States
Assistant Clinical Professor of Medicine
Division of Endocrinology
University of California San Diego
San Diego, California, United States
Professor of Endocrinology and Metabolism
Chief, Division of Endocrinology
University Hospital Policlinico Consorziale
University of Bari Aldo Moro
Bari, Italy
Clinical Professor of Medicine
University of Washington
School of Medicine
Rockwood/MultiCare Center for Diabetes and Endocrinology
Spokane, Washington, United States
None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.75 continuing professional development credits (CPD).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information about your
eligibility to claim
credit, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online
during the credit
eligibility period that is noted on the title page.
Follow these steps to claim a credit certificate for completing this activity:
We encourage you to complete an Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied
in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well
as the certificates by
accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
processing....
